Thank you for signing up to the inVolve program.
Right now the inVolve program contains important information about your disease and about vorasidenib, but this is only the beginning. We want to grow this into a truly valuable resource, learning from you and your experience to develop useful content that will help others faced with the same circumstance, now and in the future.
We want to take this opportunity to welcome you and let you know that we are committed to supporting your needs.
We hope you find the information in this program of value. Please note, that information provided on this site doesn’t replace advice from your healthcare professional. For further information, please speak with your doctor and healthcare team.
Guy Tancock
Asset Lead
Sarah Collings
Patient Affairs Manager
Roshi Weeratunge
Medical Lead Solid Tumours
Starting the journey together
“Patients and families affected by low grade glioma face the difficulty of accepting that this is an insidious and incurable disease. Having more treatment options available is so reassuring. My hope for people affected by glioma, is that new treatments can extend their lives and that the need for radiation and chemotherapy can be delayed, giving them a better quality of life”.
Lisa
“More treatment options in the low grade glioma space means hope. Hope that we are getting closer to finally finding a cure for this disease; hope that we can get access to a medication that delays the need for treatments such as chemotherapy and radiotherapy; and hope that families affected by this disease can plan for life in the long term.”
Michael
“I want all patients with glioma to live normal lives, with good neurological function, to maintain their careers, be able to support their families and their relationships and also have good, long lasting quality of life.”
Anna